These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27650859)

  • 41. [Unmet needs: patients with statin intolerance or familial hypercholesterolemia].
    Masana L; Civeira F
    Clin Investig Arterioscler; 2016 May; 28 Suppl 2():22-30. PubMed ID: 27888902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Anti-PCSK9 antibodies in type 2 diabetes and secondary prevention of cardiovascular diseases].
    López-Miranda J; Pintó X
    Clin Investig Arterioscler; 2016 May; 28 Suppl 2():31-38. PubMed ID: 27888904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Semergen; 2015 Apr; 41(3):149-57. PubMed ID: 25450438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid-lowering agents.
    Ewang-Emukowhate M; Wierzbicki AS
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):401-11. PubMed ID: 23811423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
    Agabiti Rosei E; Salvetti M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumab.
    Dahagam C; Goud A; Abdelqader A; Hendrani A; Feinstein MJ; Qamar A; Joshi PH; Swiger KJ; Byrne K; Quispe R; Jones SR; Blumenthal RS; Martin SS
    Future Cardiol; 2016 Mar; 12(2):139-48. PubMed ID: 26911578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unmet Needs in LDL-C Lowering: When Statins Won't Do!
    Krähenbühl S; Pavik-Mezzour I; von Eckardstein A
    Drugs; 2016 Aug; 76(12):1175-90. PubMed ID: 27456066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PCSK9 inhibitors.
    Farnier M
    Curr Opin Lipidol; 2013 Jun; 24(3):251-8. PubMed ID: 23652470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
    Kazi DS; Moran AE; Coxson PG; Penko J; Ollendorf DA; Pearson SD; Tice JA; Guzman D; Bibbins-Domingo K
    JAMA; 2016 Aug; 316(7):743-53. PubMed ID: 27533159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease.
    Borgia MC; Medici F
    Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary care.
    Farahani P; Levine M; Gaebel K; LeLorier J; Perrault S; Gillis J; Soon J
    Clin Invest Med; 2007; 30(2):E63-9. PubMed ID: 17716543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy.
    Koren MJ; Kereiakes D; Pourfarzib R; Winegar D; Banerjee P; Hamon S; Hanotin C; McKenney JM
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26586732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Focus on PCSK9 Inhibitors: From Genetics to Clinical Practice.
    Sabatine MS; Underberg JA; Koren M; Baum SJ
    Postgrad Med; 2016 Oct; 128 Suppl 1():31-9. PubMed ID: 27422124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.
    Blom DJ; Hala T; Bolognese M; Lillestol MJ; Toth PD; Burgess L; Ceska R; Roth E; Koren MJ; Ballantyne CM; Monsalvo ML; Tsirtsonis K; Kim JB; Scott R; Wasserman SM; Stein EA;
    N Engl J Med; 2014 May; 370(19):1809-19. PubMed ID: 24678979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives.
    Catapano AL; Pirillo A; Norata GD
    Vasc Health Risk Manag; 2017; 13():343-351. PubMed ID: 28919772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In brief: Repatha Pushtronex--a new evolocumab injection device.
    Med Lett Drugs Ther; 2016 Sep; 58(1503):120. PubMed ID: 27603964
    [No Abstract]   [Full Text] [Related]  

  • 59. NEW CLASS OF DRUGS: THERAPEUTIC RNAi INHIBITION OF PCSK9 AS A SPECIFIC LDL-C LOWERING THERAPY.
    Strat AL; Ghiciuc CM; Lupuşoru CE; Mitu F
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):228-32. PubMed ID: 27483697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.
    Pisciotta L; Sallo R; Rabacchi C; Wunsch A; Calandra S; Bertolini S
    Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):831-5. PubMed ID: 21920719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.